Last update 08 Apr 2025

Abaloparatide transdermal microneedle patch(Radius Health)

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms-
Target
PTH1R
Action
agonists
Mechanism
PTH1R agonists(Parathyroid hormone receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Osteoporosis, Postmenopausal
Originator Organization
Radius Health, Inc.Radius Health, Inc.
Active Organization-
Inactive Organization
Radius Health, Inc.Radius Health, Inc.Paladin Labs, Inc.Paladin Labs, Inc.
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Abaloparatide transdermal microneedle patch(Radius Health)
NCT01674621
/ CompletedPhase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis
100 Clinical Results associated with Abaloparatide transdermal microneedle patch(Radius Health)
Login to view more data
100 Translational Medicine associated with Abaloparatide transdermal microneedle patch(Radius Health)
Login to view more data
100 Patents (Medical) associated with Abaloparatide transdermal microneedle patch(Radius Health)
Login to view more data
100 Deals associated with Abaloparatide transdermal microneedle patch(Radius Health)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoporosis, PostmenopausalPhase 3
United States
Radius Health, Inc.Radius Health, Inc.
05 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT01674621 (CTgov)
Phase 2
Osteoporosis, Postmenopausal
250
(Abaloparatide Transdermal (50 mcg))
vafsxjqrzh(ygrxaxwrge) = qzrzgczzaz odwdenktql (gsqmmyvymr, 2.87)
View more
-
19 Dec 2016
(Abaloparatide Transdermal (100 mcg))
vafsxjqrzh(ygrxaxwrge) = nfcqwasldb odwdenktql (gsqmmyvymr, 2.96)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free